8-K Announcements
6Mar 4, 2026·SEC
Mar 3, 2026·SEC
Feb 25, 2026·SEC
Bath & Body Works, Inc. (BBWI) fundamental analysis — strengths, weaknesses & financial health based on data analysis
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Bath & Body Works, Inc. (BBWI) stock price & volume — 10-year historical chart
Bath & Body Works, Inc. (BBWI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Bath & Body Works, Inc. (BBWI) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Mar 4, 2026 | $2.05vs $1.77+15.8% | $2.7Bvs $2.6B+3.6% |
| Q4 2025 | Nov 20, 2025 | $0.35vs $0.38-8.4% | $1.6Bvs $1.6B-1.9% |
| Q3 2025 | Aug 28, 2025 | $0.37vs $0.37+0.0% | $1.5Bvs $1.6B-5.6% |
| Q2 2025 | May 29, 2025 | $0.49vs $0.42+17.3% | $1.4Bvs $1.4B+0.1% |
Bath & Body Works, Inc. (BBWI) competitors in Beauty and Personal Care Retail — business model, growth, and fundamentals comparison
Bath & Body Works, Inc. (BBWI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Bath & Body Works, Inc. (BBWI) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Jan'18 | Jan'19 | Jan'20 | Jan'21 | Jan'22 | Jan'23 | Jan'24 | Jan'25 | Jan'26 |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 12.63B | 13.24B | 5.41B | 6.43B | 7.88B | 7.56B | 7.43B | 7.31B | 7.29B |
| Revenue Growth % | 0.46% | 4.79% | -59.17% | 19.04% | 22.51% | -4.09% | -1.73% | -1.64% | -0.22% |
| Cost of Goods Sold | 7.67B | 8.34B | 3.02B | 3.34B | 4.03B | 4.3B | 4.19B | 4.07B | 4.1B |
| COGS % of Revenue | 60.74% | 62.99% | 55.84% | 51.88% | 51.09% | 56.94% | 56.44% | 55.74% | 56.26% |
| Gross Profit | 4.96B▲ 0% | 4.9B▼ 1.2% | 2.39B▼ 51.3% | 3.1B▲ 29.7% | 3.85B▲ 24.5% | 3.25B▼ 15.6% | 3.24B▼ 0.6% | 3.23B▼ 0.1% | 3.19B▼ 1.4% |
| Gross Margin % | 39.26% | 37.01% | 44.16% | 48.12% | 48.91% | 43.06% | 43.56% | 44.26% | 43.74% |
| Gross Profit Growth % | -3.24% | -1.21% | -51.28% | 29.7% | 24.52% | -15.56% | -0.58% | -0.06% | -1.39% |
| Operating Expenses | 3.23B | 3.66B | 1.35B | 1.49B | 1.85B | 1.88B | 1.95B | 1.97B | 2.06B |
| OpEx % of Revenue | 25.58% | 27.66% | 24.92% | 23.19% | 23.42% | 24.85% | 26.26% | 26.93% | 28.3% |
| Selling, General & Admin | 3.23B | 3.56B | 1.35B | 1.49B | 1.85B | 1.88B | 1.95B | 1.97B | 2.06B |
| SG&A % of Revenue | 25.58% | 26.92% | 24.92% | 23.19% | 23.42% | 24.85% | 26.26% | 26.93% | 28.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 99M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 1.73B▲ 0% | 1.24B▼ 28.4% | 1.04B▼ 15.9% | 1.6B▲ 54.2% | 2.01B▲ 25.2% | 1.38B▼ 31.5% | 1.28B▼ 6.6% | 1.27B▼ 1.5% | 1.13B▼ 11.1% |
| Operating Margin % | 13.68% | 9.35% | 19.24% | 24.93% | 25.49% | 18.2% | 17.3% | 17.33% | 15.44% |
| Operating Income Growth % | -13.73% | -28.41% | -15.93% | 54.23% | 25.25% | -31.51% | -6.61% | -1.48% | -11.06% |
| EBITDA | 2.3B | 1.83B | 1.63B | 2.13B | 2.37B | 1.6B | 1.55B | 1.55B | 1.38B |
| EBITDA Margin % | 18.2% | 13.8% | 30.12% | 33.03% | 30.09% | 21.12% | 20.92% | 21.19% | 18.93% |
| EBITDA Growth % | -8.81% | -20.53% | -10.89% | 30.53% | 11.62% | -32.67% | -2.69% | -0.39% | -10.85% |
| D&A (Non-Cash Add-back) | 571M | 590M | 588M | 521M | 363M | 221M | 269M | 282M | 254M |
| EBIT | 1.72B | 1.24B | 978M | 1.55B | 1.81B | 1.39B | 1.37B | 1.34B | 1.13B |
| Net Interest Income | -406M | -385M | -370M | -432M | -388M | -348M | -345M | -312M | -276M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 406M | 385M | 370M | 432M | 388M | 348M | 345M | 312M | 276M |
| Other Income/Expense | -416M | -380M | -432M | -482M | -586M | -331M | -264M | -238M | -244M |
| Pretax Income | 1.31B▲ 0% | 857M▼ 34.7% | 608M▼ 29.1% | 1.12B▲ 84.5% | 1.42B▲ 26.8% | 1.04B▼ 26.6% | 1.02B▼ 2.3% | 1.03B▲ 0.7% | 882M▼ 14.2% |
| Pretax Margin % | 10.39% | 6.47% | 11.25% | 17.44% | 18.05% | 13.82% | 13.74% | 14.07% | 12.1% |
| Income Tax | 329M | 213M | 148M | 257M | 348M | 251M | 143M | 230M | 233M |
| Effective Tax Rate % | 25.08% | 24.85% | 24.34% | 22.91% | 24.46% | 24.02% | 14.01% | 22.37% | 26.42% |
| Net Income | 983M▲ 0% | 644M▼ 34.5% | -366M▼ 156.8% | 844M▲ 330.6% | 1.33B▲ 57.9% | 800M▼ 40.0% | 878M▲ 9.8% | 798M▼ 9.1% | 649M▼ 18.7% |
| Net Margin % | 7.78% | 4.87% | -6.77% | 13.12% | 16.91% | 10.58% | 11.82% | 10.92% | 8.9% |
| Net Income Growth % | -15.11% | -34.49% | -156.83% | 330.6% | 57.94% | -39.98% | 9.75% | -9.11% | -18.67% |
| Net Income (Continuing) | 983M | 644M | 460M | 865M | 1.07B | 794M | 878M | 798M | 649M |
| Discontinued Operations | 0 | 0 | -826M | -21M | 258M | 6M | 0 | 0 | 0 |
| Minority Interest | 2M | 4M | 4M | 1M | 1M | 1M | 1M | 2M | 0 |
| EPS (Diluted) | 3.42▲ 0% | 2.31▼ 32.5% | -1.33▼ 157.6% | 3.00▲ 325.6% | 4.88▲ 62.7% | 3.43▼ 29.7% | 3.83▲ 11.7% | 3.61▼ 5.7% | 3.07▼ 15.0% |
| EPS Growth % | -14.07% | -32.46% | -157.58% | 325.56% | 62.67% | -29.71% | 11.66% | -5.74% | -14.96% |
| EPS (Basic) | 3.46 | 2.33 | -1.33 | 3.04 | 4.96 | 3.45 | 3.89 | 3.62 | 3.07 |
| Diluted Shares Outstanding | 287.42M | 276.16M | 276M | 281M | 273M | 233M | 229M | 221M | 211.61M |
| Basic Shares Outstanding | 287.06M | 276M | 276M | 278M | 269M | 232M | 225.94M | 220M | 211.61M |
| Dividend Payout Ratio | 69.79% | 103.42% | - | 9.83% | 9% | 23.25% | 20.73% | 22.18% | 25.73% |
Bath & Body Works, Inc. (BBWI) balance sheet — assets, liabilities & shareholders' equity
| Line item | Jan'18 | Jan'19 | Jan'20 | Jan'21 | Jan'22 | Jan'23 | Jan'24 | Jan'25 | Jan'26 |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 3.29B | 3.26B | 3.25B | 5.58B | 3.01B | 2.27B | 2.12B | 1.82B | 2.02B |
| Cash & Short-Term Investments | 1.51B | 1.41B | 1.5B | 3.57B | 1.98B | 1.23B | 1.08B | 674M | 953M |
| Cash Only | 1.51B | 1.41B | 1.5B | 3.57B | 1.98B | 1.23B | 1.08B | 674M | 953M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 310M | 367M | 306M | 148M | 240M | 226M | 224M | 205M | 180M |
| Days Sales Outstanding | 8.96 | 10.12 | 20.66 | 8.4 | 11.11 | 10.91 | 11.01 | 10.24 | 9.01 |
| Inventory | 1.24B | 1.25B | 1.29B | 572M | 709M | 709M | 710M | 734M | 699M |
| Days Inventory Outstanding | 58.99 | 54.63 | 155.65 | 62.55 | 64.26 | 60.11 | 61.81 | 65.78 | 62.2 |
| Other Current Assets | 228M | 232M | 153M | 1.29B | 81M | 99M | 97M | 210M | 187M |
| Total Non-Current Assets | 4.86B | 4.83B | 6.88B | 5.99B | 3.02B | 3.23B | 3.35B | 3.05B | 3.05B |
| Property, Plant & Equipment | 2.89B | 2.82B | 5.54B | 1.99B | 2.03B | 2.24B | 2.28B | 2.08B | 2.07B |
| Fixed Asset Turnover | 4.37x | 4.70x | 0.98x | 3.24x | 3.88x | 3.37x | 3.26x | 3.52x | 3.53x |
| Goodwill | 1.35B | 1.35B | 628M | 628M | 628M | 628M | 628M | 628M | 628M |
| Intangible Assets | 411M | 411M | 411M | 165M | 165M | 165M | 165M | 165M | 165M |
| Long-Term Investments | 81M | 89M | 118M | 119M | 126M | 124M | 120M | 26M | 0 |
| Other Non-Current Assets | 109M | 102M | 100M | 3.04B | 23M | 31M | 15M | 24M | 77M |
| Total Assets | 8.15B▲ 0% | 8.09B▼ 0.7% | 10.13B▲ 25.2% | 11.57B▲ 14.3% | 6.03B▼ 47.9% | 5.49B▼ 8.8% | 5.46B▼ 0.6% | 4.87B▼ 10.8% | 5.07B▲ 4.0% |
| Asset Turnover | 1.55x | 1.64x | 0.53x | 0.56x | 1.31x | 1.38x | 1.36x | 1.50x | 1.44x |
| Asset Growth % | -0.26% | -0.72% | 25.15% | 14.28% | -47.92% | -8.83% | -0.56% | -10.82% | 4.04% |
| Total Current Liabilities | 2.03B | 1.99B | 2.37B | 2.83B | 1.29B | 1.38B | 1.29B | 1.23B | 1.59B |
| Accounts Payable | 717M | 711M | 647M | 345M | 435M | 455M | 380M | 338M | 465M |
| Days Payables Outstanding | 34.11 | 31.12 | 78.25 | 37.72 | 39.43 | 38.58 | 33.08 | 30.29 | 41.38 |
| Short-Term Debt | 87M | 72M | 61M | 0 | 0 | 0 | 0 | 0 | 475M |
| Deferred Revenue (Current) | 267M | 316M | 330M | 115M | 148M | 195M | 198M | 197M | 0 |
| Other Current Liabilities | 20M | 27M | 23M | 1.6B | 0 | 0 | 0 | 0 | 579M |
| Current Ratio | 1.62x | 1.64x | 1.37x | 1.97x | 2.33x | 1.64x | 1.64x | 1.48x | 1.27x |
| Quick Ratio | 1.01x | 1.01x | 0.83x | 1.77x | 1.78x | 1.13x | 1.09x | 0.88x | 0.83x |
| Cash Conversion Cycle | 33.84 | 33.63 | 98.07 | 33.22 | 35.95 | 32.45 | 39.73 | 45.73 | 29.83 |
| Total Non-Current Liabilities | 6.87B | 6.97B | 9.25B | 9.41B | 6.25B | 6.32B | 5.8B | 5.02B | 4.76B |
| Long-Term Debt | 5.71B | 5.74B | 5.49B | 6.37B | 4.85B | 4.86B | 4.39B | 3.88B | 3.61B |
| Capital Lease Obligations | 0 | 19M | 3.05B | 942M | 989M | 1.01B | 1B | 883M | 867M |
| Deferred Tax Liabilities | 238M | 226M | 219M | 141M | 157M | 168M | 147M | 24M | 65M |
| Other Non-Current Liabilities | 924M | 985M | 490M | 1.96B | 253M | 276M | 261M | 233M | 213M |
| Total Liabilities | 8.9B | 8.96B | 11.62B | 12.23B | 7.54B | 7.7B | 7.09B | 6.25B | 6.35B |
| Total Debt | 5.79B | 5.81B | 9.08B | 7.48B | 6.01B | 6.05B | 5.57B | 4.96B | 4.95B |
| Net Debt | 4.28B | 4.4B | 7.58B | 3.91B | 4.03B | 4.82B | 4.49B | 4.29B | 4B |
| Debt / Equity | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | 2.52x | 3.18x | 5.58x | 3.52x | 2.53x | 3.79x | 3.59x | 3.20x | 3.59x |
| Net Debt / EBITDA | 1.86x | 2.41x | 4.66x | 1.84x | 1.70x | 3.02x | 2.89x | 2.77x | 2.90x |
| Interest Coverage | 4.26x | 3.21x | 2.81x | 3.71x | 5.18x | 3.95x | 3.72x | 4.06x | 4.08x |
| Total Equity | -751M▲ 0% | -865M▼ 15.2% | -1.5B▼ 72.8% | -661M▲ 55.8% | -1.52B▼ 129.5% | -2.2B▼ 45.3% | -1.63B▲ 26.2% | -1.38B▲ 14.9% | -1.28B▲ 7.5% |
| Equity Growth % | -3.3% | -15.18% | -72.83% | 55.79% | -129.5% | -45.29% | 26.22% | 14.94% | 7.52% |
| Book Value per Share | -2.61 | -3.13 | -5.42 | -2.35 | -5.56 | -9.46 | -7.10 | -6.26 | -6.04 |
| Total Shareholders' Equity | -753M | -869M | -1.5B | -662M | -1.52B | -2.21B | -1.63B | -1.39B | -1.28B |
| Common Stock | 141M | 141M | 142M | 143M | 134M | 122M | 120M | 115M | 0 |
| Retained Earnings | -1.43B | -1.48B | -2.18B | -1.42B | -1.8B | -2.4B | -1.84B | -1.58B | 0 |
| Treasury Stock | -162M | -358M | -358M | -358M | -822M | -822M | -822M | -822M | 0 |
| Accumulated OCI | 24M | 59M | 52M | 83M | 80M | 78M | 75M | 71M | 0 |
| Minority Interest | 2M | 4M | 4M | 1M | 1M | 1M | 1M | 2M | 0 |
Bath & Body Works, Inc. (BBWI) cash flow — operating, investing & free cash flow history
| Line item | Jan'18 | Jan'19 | Jan'20 | Jan'21 | Jan'22 | Jan'23 | Jan'24 | Jan'25 | Jan'26 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 1.41B | 1.38B | 1.24B | 2.04B | 1.49B | 1.14B | 954M | 886M | 1.1B |
| Operating CF Margin % | 11.13% | 10.4% | 22.87% | 31.69% | 18.93% | 15.13% | 12.84% | 12.13% | 15.11% |
| Operating CF Growth % | -25.61% | -2.06% | -10.24% | 64.97% | -26.83% | -23.32% | -16.61% | -7.13% | 24.38% |
| Net Income | 983M | 644M | -366M | 844M | 1.33B | 800M | 878M | 798M | 649M |
| Depreciation & Amortization | 571M | 590M | 588M | 521M | 363M | 221M | 269M | 282M | 254M |
| Stock-Based Compensation | 102M | 97M | 87M | 50M | 46M | 38M | 43M | 40M | 0 |
| Deferred Taxes | -108M | -52M | -29M | 33M | 45M | 17M | -128M | -112M | 63M |
| Other Non-Cash Items | -22M | 155M | 1.05B | 214M | 195M | 0 | -26M | -29M | 23M |
| Working Capital Changes | -120M | -57M | -99M | 377M | -490M | 68M | -82M | -93M | 113M |
| Change in Receivables | -13M | -63M | 31M | 38M | -64M | 11M | 2M | 18M | 25M |
| Change in Inventory | -137M | -40M | -40M | 3M | -177M | 0 | -2M | -26M | 37M |
| Change in Payables | 50M | 29M | -93M | 166M | -86M | 44M | -109M | -50M | 111M |
| Cash from Investing | -698M | -609M | -480M | -219M | -259M | -328M | -286M | -162M | -227M |
| Capital Expenditures | -707M | -629M | -458M | -228M | -270M | -328M | -298M | -226M | -237M |
| CapEx % of Revenue | 5.6% | 4.75% | 8.47% | 3.54% | 3.43% | 4.34% | 4.01% | 3.09% | 3.25% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | 19M | 20M | -22M | 9M | 11M | 0 | 12M | 63M | 10M |
| Cash from Financing | -1.13B | -872M | -666M | 610M | -3.19B | -1.56B | -815M | -1.13B | -599M |
| Debt Issued (Net) | 7M | 11M | -308M | 703M | -1.73B | -9M | -462M | -539M | -14M |
| Equity Issued (Net) | -1000K | -1000K | 1000K | 1000K | -1000K | -1000K | -1000K | -1000K | -1000K |
| Dividends Paid | -686M | -666M | -332M | -83M | -120M | -186M | -182M | -177M | -167M |
| Share Repurchases | -446M | -198M | 0 | 0 | -1.96B | -1.31B | -148M | -401M | -401M |
| Other Financing | -2M | -20M | -27M | -18M | 683M | -61M | -23M | -15M | -17M |
| Net Change in Cash | -419M▲ 0% | -102M▲ 75.7% | 86M▲ 184.3% | 2.43B▲ 2730.2% | -1.95B▼ 180.3% | -747M▲ 61.8% | -148M▲ 80.2% | -410M▼ 177.0% | 279M▲ 168.0% |
| Free Cash Flow | 699M▲ 0% | 748M▲ 7.0% | 778M▲ 4.0% | 1.81B▲ 132.8% | 1.22B▼ 32.5% | 816M▼ 33.2% | 656M▼ 19.6% | 660M▲ 0.6% | 865M▲ 31.1% |
| FCF Margin % | 5.53% | 5.65% | 14.39% | 28.15% | 15.5% | 10.79% | 8.83% | 9.03% | 11.86% |
| FCF Growth % | -22.33% | 7.01% | 4.01% | 132.78% | -32.52% | -33.22% | -19.61% | 0.61% | 31.06% |
| FCF per Share | 2.43 | 2.71 | 2.82 | 6.44 | 4.48 | 3.50 | 2.86 | 2.99 | 4.09 |
| FCF Conversion (FCF/Net Income) | 1.43x | 2.14x | -3.38x | 2.42x | 1.12x | 1.43x | 1.09x | 1.11x | 1.70x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bath & Body Works, Inc. (BBWI) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Invested Capital (ROIC) | 50.16% | 39.25% | 26.28% | 16.22% | 25.77% | 52.24% | 40.2% | 35.17% | 32.94% | 30.03% |
| Gross Margin | 40.76% | 39.26% | 37.01% | 44.16% | 48.12% | 48.91% | 43.06% | 43.56% | 44.26% | 43.74% |
| Net Margin | 9.21% | 7.78% | 4.87% | -6.77% | 13.12% | 16.91% | 10.58% | 11.82% | 10.92% | 8.9% |
| Interest Coverage | 5.08x | 4.26x | 3.21x | 2.81x | 3.71x | 5.18x | 3.95x | 3.72x | 4.06x | 4.08x |
| FCF Conversion | 1.63x | 1.43x | 2.14x | -3.38x | 2.42x | 1.12x | 1.43x | 1.09x | 1.11x | 1.70x |
| Revenue Growth | 3.46% | 0.46% | 4.79% | -59.17% | 19.04% | 22.51% | -4.09% | -1.73% | -1.64% | -0.22% |
Bath & Body Works, Inc. (BBWI) SEC filings — annual & quarterly reports (10-K, 10-Q)
Mar 4, 2026·SEC
Mar 3, 2026·SEC
Feb 25, 2026·SEC
Bath & Body Works, Inc. (BBWI) stock FAQ — growth, dividends, profitability & financials explained
Bath & Body Works, Inc. (BBWI) reported $7.29B in revenue for fiscal year 2025. This represents a 16% decrease from $8.64B in 1996.
Bath & Body Works, Inc. (BBWI) saw revenue decline by 0.2% over the past year.
Yes, Bath & Body Works, Inc. (BBWI) is profitable, generating $649.0M in net income for fiscal year 2025 (8.9% net margin).
Yes, Bath & Body Works, Inc. (BBWI) pays a dividend with a yield of 4.11%. This makes it attractive for income-focused investors.
Bath & Body Works, Inc. (BBWI) generated $865.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Bath & Body Works, Inc. (BBWI) financial analysis — history, returns, DCA and operating performance tools
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates